Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs.

Department of Social Medicine, University of Bristol, Canynge Hall, Bristol, UK.
Expert Review of Vaccines (Impact Factor: 4.22). 08/2009; 8(7):851-61. DOI: 10.1586/erv.09.48
Source: PubMed

ABSTRACT Effective vaccines provide direct protection to immunized individuals, but may also provide benefits to unvaccinated individuals by reducing transmission and thereby lowering the risk of infection. Such herd immunity effects have been demonstrated following the introduction of meningococcal serogroup C conjugate (MCC) vaccines, with reductions in disease attack rates in unimmunized individuals and significantly lower serogroup C carriage attributable to the vaccine introduction. In the UK, targeting teenagers for immunization was crucial in maximizing indirect effects, as most meningococcal transmission occurs in this age group. Questions remain regarding the duration of herd protection and the most appropriate long-term immunization strategies. The magnitude of the herd effects following MCC vaccination was largely unanticipated, and has important consequences for the design and evaluation of new meningococcal vaccines.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Meningococcal serogroup C (MenC) specific antibody levels decline rapidly after a single primary MenC conjugate (MenCC) vaccination in preschool children. A second MenCC vaccination during (pre)adolescence might attain longer lasting individual and herd protection. We aimed to establish an appropriate age for a (pre)adolescent MenCC booster vaccination.
    PLoS ONE 01/2014; 9(6):e100651. DOI:10.1371/journal.pone.0100651 · 3.53 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Consultant 2 Summary The GAVI supported vaccinations differ widely in there potential effect on women's health and maternal health. Vaccines with an impact on women's health include hep B and HPV. These two vaccines address infections, which have been shown to lead to severe morbidity and mortality in adults. Cervical cancer is a leading cause of death in women in many low and middle income countries and HPV 16/18 cause 70% of cervical cancers. Liver cancer, albeit less important than cervical cancer still causes substantial deaths in women. As such, both cancers also affect maternal health. In high income countries around 3% of cervical cancers are diagnosed during pregnancy. The diagnosis and therapy of cervical cancer in pregnancy puts stress on women, and termination of pregnancy is often needed to prevent negative consequences for the mother. Primary prevention through vaccination might have here an important impact. The impact of a hep B infection on morbidity and mortality in pregnancy is unclear as too few studies have been published. Still some effect of vaccination, although probably small at population level, can be assumed. Tetanus vaccination during childhood and pregnancy has most probable already reduced the burden of maternal tetanus substantially. Few cases, often due to abortion, are still described today.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Foot-and-mouth disease (FMD) causes ongoing losses in Turkey and poses a threat to FMD free Europe. Control relies on mass vaccination of cattle every six months. Between September 2011 and July 2012, four retrospective outbreak investigations were performed in Turkey to assess FMD Asia-1 vaccine effectiveness (VE) in cattle, that is, vaccine efficacy assessed under field conditions. After adjustment for confounding, the new FMD Asia-1 TUR 11 vaccine had a VE against disease of 69% [95% CI: 50% to 81%]. There was no evidence that the old FMD Asia-1 Shamir vaccine provided adequate protection, with 69% of those vaccinated 2-5 times affected by clinical FMD. Efforts to achieve sustained herd immunity, through biannual vaccination of cattle are compromised by rapid population turnover and waning protection. Between autumn 2012 and spring 2013, a prospective field study was conducted, assessing immunity after routine vaccination. Four to five months after vaccination, only a third of single-vaccinated cattle had antibody levels above a threshold associated with protection. It was not until animals had received three vaccine doses in their lifetime that most maintained antibody levels above this threshold (64% to 86% depending on serotype). Many vaccinated animals will be unprotected for much of the year. Compared to a single-dose, a primary vaccination course of two-doses, given one month apart, greatly improved immunity. A dynamic model of the Turkish cattle population estimated that six months after the last round of vaccination almost half the cattle ≤24 months old remained unvaccinated. Only 50% of all cattle would have been vaccinated more than once in their life, with the last dose given ≤6 months ago. The FMD vaccination programme in Anatolian Turkey did not produce the high levels of immunity needed to control FMD without additional control measures.
    07/2014, Degree: PhD, Supervisor: Paton,D.J., Gubbins,S., Stärk,K.D.C., Pfeiffer,D.U.


Available from
Aug 1, 2014